CBNK vs INCY · P/E 9.9, rev $137.9M vs P/E 14, rev $5.14B
Capital Bancorp (CBNK) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Capital Bancorp (CBNK) is a banks - regional company listed on NASDAQ.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported CBNK revenue for 2026-06-30 was $137.9M. Net income was $26.3M. CBNK currently screens at market cap $536.9M and trailing P/E 9.9.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
CBNK currently screens at market cap $536.9M and trailing P/E 9.9. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the CBNK and INCY stock pages for the full models.
Not investment advice.